Insight

Tracey O’Brien: Excited to share this year’s cancer in NSW 2024 report

Tracey O’Brien/LinkedIn

Dec 20, 2024, 22:56

Tracey O’Brien: Excited to share this year’s cancer in NSW 2024 report

Tracey O’Brien, NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, shared a post on LinkedIn:

“I’m excited to share this year’s Cancer in NSW 2024 report, which spotlights the world-leading cancer control efforts taking place in NSW.

In developing this year’s report, we set out to shine a light on people – those dedicated to improving cancer outcomes and experiences, and of course the people living with and beyond cancer.

What is clear is that despite our collective efforts, cancer continues to affect far too many people in our community. To create real change, we must work together.

As the year comes to a close, I’d like to celebrate the people working around the clock to better understand this devastating disease. Importantly, I’d like to acknowledge the challenges faced by those living with cancer and their families.

You can read the report, here.”

NSW

Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program.

Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group.

In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category.

In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University).

Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.